You have 9 free searches left this month | for more free features.

Rate of engraftment

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023

Allogeneic Hematopoietic Cell Transplantation Trial in Cleveland (Nicotinamide riboside (NR))

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation
  • Nicotinamide riboside (NR)
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Bone Marrow Transplant Complications, Fatigue, Vital Signs Trial in Ankara (Reiki)

Recruiting
  • Bone Marrow Transplant Complications
  • +3 more
  • Reiki
  • Ankara, None Selected, Turkey
    Nursemin Ünal
Jan 19, 2023

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
  • Myeloid Hematological Malignancies
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

Not yet recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 5, 2023

    Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

    Recruiting
    • Hematological Disease
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Feb 6, 2023

    B-cell NHL, CLL Trial (CARCIK-CD19)

    Not yet recruiting
    • B-cell NHL
    • CLL
    • CARCIK-CD19
    • (no location specified)
    May 19, 2023

    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

    Recruiting
    • Primary Immune Deficiency Disorder
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University
    Oct 20, 2022

    Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with

    Recruiting
    • Bone Marrow Failure Syndromes
    • MRD-BMT with Fludarabine-based RIC for Acquired AA
    • +2 more
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    May 6, 2022

    Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

    Recruiting
    • Aplastic Anemia
    • Bone Marrow Failure Syndrome
    • Anti-Thymocyte Globulin (Rabbit)
    • +8 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 26, 2022

    Immunodeficiencies Trial in Philadelphia (CliniMACs)

    Active, not recruiting
    • Immunodeficiencies
    • CliniMACs
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Mar 1, 2022

    Ulcerative Colitis Trial in Minneapolis (Fecal microbiota, Placebo)

    Active, not recruiting
    • Ulcerative Colitis
    • Fecal microbiota
    • Placebo
    • Minneapolis, Minnesota
      University of Minnesota
    Sep 14, 2022

    Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

    Recruiting
    • Hematologic Disorders
    • Miltenyi CliniMACS® CD34 Reagent System
    • Aurora, Colorado
      University of Colorado
    Feb 22, 2022

    Hematological Malignancy Trial in Detroit (Bortezomib)

    Recruiting
    • Hematological Malignancy
    • Detroit, Michigan
      Henry Ford hospital
    Dec 23, 2021

    AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

    Not yet recruiting
    • AML
    • +5 more
    • Infusion of CD34 selected hematopoietic stem cells
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 14, 2023

    Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

    Not yet recruiting
    • Graft Vs Host Disease
    • +5 more
    • CliniMACS® device
    • (no location specified)
    Jul 20, 2023

    Cancer Metastatic, Prostate Cancer, Breast Cancer Trial in Pierre-Bénite (Patient sampling.)

    Not yet recruiting
    • Cancer Metastatic
    • +5 more
    • Patient sampling.
    • Pierre-Bénite, France
    • +1 more
    Jul 22, 2022

    T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

    Recruiting
    • T-cell Non-Hodgkin Lymphoma
    • Lymphoma, Extranodal NK-T-Cell
    • Busan, Korea, Republic of
    • +1 more
    Aug 17, 2022

    Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

    Recruiting
    • Hematologic Neoplasms
    • Milan, Italy
      European Institute of Oncology
    Sep 24, 2021

    Graft Failure Trial in Australia, Canada, Israel (Emapalumab)

    Terminated
    • Graft Failure
    • Melbourne, Australia
    • +4 more
    Jul 25, 2022